about
Advances in the treatment of invasive neonatal candidiasisPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsEfficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.Time-course proteome analysis reveals the dynamic response of Cryptococcus gattii cells to fluconazoleMitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in FungiSynthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)Voriconazole: the newest triazole antifungal agentComparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.Epidemiology and treatment approaches in management of invasive fungal infectionsAnti-Candida activity of Quercus infectoria gall extracts against Candida speciesVoriconazole in the management of nosocomial invasive fungal infections.Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.Interplay between fungicides and parasites: Tebuconazole, but not copper, suppresses infection in a Daphnia-Metschnikowia experimental modelTreatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.In search of the holy grail of antifungal therapyBlad-Containing Oligomer Fungicidal Activity on Human Pathogenic Yeasts. From the Outside to the Inside of the Target Cell.Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium sppMIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.An integrated approach for identification and target validation of antifungal compounds active against Erg11p.Advances in synthetic approach to and antifungal activity of triazoles.Molecular characterization of propolis-induced cell death in Saccharomyces cerevisiae.Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.Pediatric Invasive Aspergillosis.Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus
P2860
Q27022585-8A4F1EF2-A838-46C8-881D-5FA7C7E730D2Q27025299-7A55EFAF-5EAE-4B01-8893-8709890CC088Q28345150-966BCD10-26FE-44FB-8855-069D9DEC9252Q28482096-3C48A1F1-C2B7-4504-B61D-F8EFB8E20535Q28552733-43E92603-0242-417B-8D5E-C2AB6B86141AQ33719218-2CCBF93E-10D9-4DD3-851E-2F952858E0B3Q33946021-A12D03D7-9F62-433E-9FA3-A9E2859BFFA4Q33959480-AC687EEB-5E44-4373-B8F6-B8E552E84F0FQ33983618-91C7C459-3570-4B72-A7E2-EE3D75EC2129Q34749162-B4F62D66-8EB1-4DE6-A0E0-ED562D7BBDEDQ35089772-DA3759EA-2EDB-41C7-AAB2-86E90425C8A7Q35098733-61461A09-DA35-4DEB-A30E-4408A683C6D8Q35166823-46DB3F25-FDDE-44E4-8A00-9EB3F183C395Q35745822-4C4DDA97-BB88-48FC-904C-71F09483A122Q36094939-A102D4E3-3DD2-43C1-80D1-909855F1E124Q36288436-CF7FF40B-9DC0-4F9F-BDBB-F48B2282D9FBQ36511881-448A7236-DC65-4D6E-A540-A71088457109Q36672181-1DF7D6D6-F4F1-417C-806A-274FB51C07F0Q37438608-BDC12F6A-9A55-45BA-95D5-518F9041B7BBQ37474433-341DC89D-0501-4D74-841C-FD974961AAB4Q37568382-E2BD353A-5F2F-492B-9BA6-818B4638F664Q37598686-028BF35B-1326-4FAC-85BF-47FF7C86FEF9Q39652699-E1BEB140-1D68-4F78-B326-352C1564CC1EQ41091429-DEA93F4B-38FF-49E6-A055-05D27ABF7733Q41453215-A0312B1F-9422-4CE6-B0B8-E17B2CA7E0E7Q42173257-5B251ADA-9469-489A-B166-592E2E363165Q42206400-924AD501-47E0-4159-A5CA-346DE86A6CE7Q42226762-48F1E8A4-37B3-4AA2-837B-3063C584455DQ42432990-A472912E-5BA9-4CA7-9E46-1BF5A0A94C07Q49612998-FC0A300B-9C99-45A8-8DA8-DCF3AF62C447Q58799698-A8AF0D52-779B-426D-B8F4-8014719B2322
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Organism-dependent fungicidal activities of azoles.
@ast
Organism-dependent fungicidal activities of azoles.
@en
type
label
Organism-dependent fungicidal activities of azoles.
@ast
Organism-dependent fungicidal activities of azoles.
@en
prefLabel
Organism-dependent fungicidal activities of azoles.
@ast
Organism-dependent fungicidal activities of azoles.
@en
P2093
P2860
P1476
Organism-dependent fungicidal activities of azoles.
@en
P2093
E K Manavathu
J L Cutright
P H Chandrasekar
P2860
P304
P407
P577
1998-11-01T00:00:00Z